Siemens is improving diagnosis and treatment of diseases with a unique imaging system that locates metabolic processes using nuclear detectors and x-ray images with high accuracy.
Symbia IntevoTM*, the world's first xSPECT* system, integrates metabolic information from single photon emission computed tomography (SPECT) into computed tomography (CT) images.
Previously, SPECT/CT images had low spatial resolution and physicians needed extensive experience and additional follow-up studies to decide whether a metabolic anomaly reflected a tumor or other diseases. Symbia Intevo also enables physicians to determine tumor size and thus plan treatment and monitor outcomes.
During SPECT examinations, patients are given low doses of radiopharmaceuticals that emit radiation when they react with a particular body tissue. Different metabolic processes can thus be observed depending on the agent administered. To determine the location of a metabolic disorder in the body, SPECT information is overlaid with CT images showing the anatomy of the body.
Until now, the problem has been that SPECT examinations offer only low spatial resolution and the high-precision CT images have to be adapted to match them. It can happen that the resulting image no longer clearly shows whether the metabolic disorder observed is inside or outside the bone. It would initially be unclear whether the anomaly was caused by a tumor in the bone or something else, such as a soft tissue inflammation.
The developers at Siemens Healthcare have now integrated SPECT and CT data in such a way that the high spatial resolution of the x-ray images remains intact and the SPECT images are significantly improved. The two datasets are generated sequentially during reconstruction in the same device using reference parameters such as the position of the detectors relative to the patient.
New, iterative image reconstruction algorithms refine the data in several passes. It was not previously possible to perform such complex calculation processes at the high resolution used in the CT images. That's why, in addition to new software, Symbia Intevo is also equipped with a powerful 64-bit computer.
The precise xSPECT data also makes it possible to determine the volume of the radiopharmaceutical used. This means that physicians can observe the change in metabolic activity and check whether their treatment is working.
Symbia Intevo also utilizes state-of-the-art algorithms that use the CT measurements to assign each voxel (three-dimensional pixel) in the xSPECT image to a particular class-fatty tissue, soft tissue, air, or hard (external) and soft (internal) bone areas. This makes it easy to recognize the body part where the metabolic disorder is located.
* Symbia Intevo and xSPECT are not commercially available in all countries. Due to regulatory reasons their future availability cannot be guaranteed.
Dr. Norbert Aschenbrenner | Siemens InnovationNews
UTSA study describes new minimally invasive device to treat cancer and other illnesses
02.12.2016 | University of Texas at San Antonio
Earlier Alzheimer's diagnosis may be possible with new imaging compound
02.11.2016 | Washington University School of Medicine
Have you ever wondered how you see the world? Vision is about photons of light, which are packets of energy, interacting with the atoms or molecules in what...
A multi-institutional research collaboration has created a novel approach for fabricating three-dimensional micro-optics through the shape-defined formation of porous silicon (PSi), with broad impacts in integrated optoelectronics, imaging, and photovoltaics.
Working with colleagues at Stanford and The Dow Chemical Company, researchers at the University of Illinois at Urbana-Champaign fabricated 3-D birefringent...
In experiments with magnetic atoms conducted at extremely low temperatures, scientists have demonstrated a unique phase of matter: The atoms form a new type of quantum liquid or quantum droplet state. These so called quantum droplets may preserve their form in absence of external confinement because of quantum effects. The joint team of experimental physicists from Innsbruck and theoretical physicists from Hannover report on their findings in the journal Physical Review X.
“Our Quantum droplets are in the gas phase but they still drop like a rock,” explains experimental physicist Francesca Ferlaino when talking about the...
The Max Planck Institute for Physics (MPP) is opening up a new research field. A workshop from November 21 - 22, 2016 will mark the start of activities for an innovative axion experiment. Axions are still only purely hypothetical particles. Their detection could solve two fundamental problems in particle physics: What dark matter consists of and why it has not yet been possible to directly observe a CP violation for the strong interaction.
The “MADMAX” project is the MPP’s commitment to axion research. Axions are so far only a theoretical prediction and are difficult to detect: on the one hand,...
Broadband rotational spectroscopy unravels structural reshaping of isolated molecules in the gas phase to accommodate water
In two recent publications in the Journal of Chemical Physics and in the Journal of Physical Chemistry Letters, researchers around Melanie Schnell from the Max...
16.11.2016 | Event News
01.11.2016 | Event News
14.10.2016 | Event News
05.12.2016 | Power and Electrical Engineering
05.12.2016 | Information Technology
05.12.2016 | Earth Sciences